A Phase II Randomized Open Label Study of KLH-2109 in Patients With Endometriosis
NCT01629420 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2014-05-30
Summary
The purpose of this study is to evaluate the efficacy and safety of KLH-2109 in patients with endometriosis.
Conditions
- Endometriosis
Interventions
- DRUG
-
KLH-2109
- DRUG
-
KLH-2109
Sponsors & Collaborators
-
Kissei Pharmaceutical Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- Japan
More Related Trials
-
A Study to Assess the Efficacy and Safety of OBE2109 in Subjects With Endometriosis
NCT02778399 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of MT-2990 in Women With Endometriosis
NCT03840993 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain
NCT05560646 ·Status: COMPLETED ·Phase: PHASE2
-
A Survey on Efficacy and Safety in Patients With Endometriosis
NCT02921763 ·Status: COMPLETED
-
A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia and Pain
NCT05445167 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia
NCT05440383 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase IIa Clinical Study to Assess the Efficacy and Safety of GenSci048 in Patients With Moderate to Severe Endometriosis-Associated Pain
NCT06963177 ·Status: RECRUITING ·Phase: PHASE2
-
Levonorgestrel-releasing Intrauterine System in Patients With Endometriosis
NCT02158845 ·Status: COMPLETED ·Phase: PHASE4
-
Subdermal Implant-bioabsorbable Gestrinone Pellet for Endometriosis Pelvic Pain Treatment
NCT05570786 ·Status: COMPLETED ·Phase: PHASE2
-
BGS649 Monotherapy in Moderate to Severe Endometriosis Patients
NCT01190475 ·Status: COMPLETED ·Phase: PHASE2
-
Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain
NCT04372121 ·Status: TERMINATED ·Phase: PHASE3
-
Letrozole in the Treatment of Severe and Recurrent Endometriosis
NCT00240942 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety & Efficacy Study of BGS649 in Women With Refractory Endometriosis
NCT01116440 ·Status: TERMINATED ·Phase: PHASE2
-
The Pharmacokinetic(PK)/Pharmacodynamics(PD) Study of SHR7280 Tablets in Premenopausal Subjects With Endometriosis.
NCT04417972 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Global Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Women With Moderate to Severe Endometriosis-associated Pain
NCT02143713 ·Status: COMPLETED ·Phase: PHASE3
-
Medroxyprogesterone Acetate vs LNG-IUS in Early-stage Endometrioid Carcinoma and Atypical Hyperplasia Patients
NCT05565573 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Dopamine Receptor Agonist Therapy for Pain Relief in Women Suffering From Endometriosis: A Pilot Study
NCT02542410 ·Status: COMPLETED ·Phase: PHASE2
-
The Impact of a Novel GnRH Antagonist With Add-back Therapy for Treatment of Uterine Fibroids and Endometriosis on Hemostasis Parameters
NCT07173127 ·Status: RECRUITING ·Phase: NA
-
Endometriosis Trial: Study of NBI-56418 in Endometriosis
NCT00109512 ·Status: COMPLETED ·Phase: PHASE2
-
Postoperative Desogestrel for Endometriosis Related Pain
NCT01559480 ·Status: COMPLETED ·Phase: NA
-
A Study of HS-10518 in Healthy Female Participants
NCT06118827 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Efficacy of Injectable Contraceptive and Oral Contraceptive Administered After Surgical Treatment of Endometriosis With Pain
NCT01056042 ·Status: COMPLETED ·Phase: PHASE4
-
Endometrioma Per se Versus Treatment Related Reduction in Ovarian Reserve (ERROR-2 Trial)
NCT03620838 ·Status: UNKNOWN
-
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of SKI2670
NCT02202408 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for Pregnancy
NCT04756037 ·Status: COMPLETED ·Phase: PHASE3